Prevalence of human papilloma virus infection of the uterine cervix in women with abnormal cervical cytology

Purpose of investigation: To determine the prevalence of human papillomavirus (HPV) using polymerase chain reaction (PCR) in women with abnormal cytology results.

Methods: A prospective study of 215 women with abnormal cytology results referred consecutively to the cervical pathology clinic was carried out. A second cervical cytology using the Bethesda System was performed on all the patients to confirm the initial diagnosis, as well as to test for the presence of HPV by PCR and a colposcopy and punch biopsy in cases presenting with an abnormal pattern on colposcopy. The sensivitiy, specificity, and positive and negative predictive value (PPV and NPV) were calculated using 2 x 2 tables.

Results: The women aged 35 years or younger presented a higher percentage of HPV infection (85.6%) than the women over 35 years of age (54%). The highest percentage of women with a positive result for HPV was found in those with a cytological high-grade squamous intraepithelial lesion (HSIL) (85.5%), as compared with 47.4% of the women with a cytological low-grade squamous intraepithelial lesion (LSIL). HPV infection has a high negative predictive value (93.2% of cases) and a high sensitivity (93.5%) for the detection of HSIL by biopsy, although the specificity and positive predictive value were low, 51.5% and 52.1%, respectively.

Conclusion: Patients with cytological HSIL have a high prevalence of HPV infection.

Prevalence; Human papillomavirus infection; Abnormal cytology

[1] Clifford G.M., Smith J.S., Plummer M., Munoz N., Franceschi S "Human papillomavirus type in invasive cervical cancer worldwide: a meta-analysis carcinoma of the cervix". Br. J. Cancer, 2003, 88, 63.

[2] Chaouki N., Bosch F.X., Munoz N., Meijer C.J.L.M., El Gueddari B., El Ghazi A. et al.: "The viral origin of cervical cancer in Rabat, Morocco". Int. J. Cancer, 1998, 75, 546.

[3] Chichareon S., Herrero R., Munoz N., Bosch F.X., Jacobs M.V., Deacon J. et al.: "Risk factors for cervical cancer in Thailand: a case-control study". J. Natl. Cancer Inst., 1998, 90, 50.

[4] Ngelangel C., Munoz N., Bosch F.X., Limson G.M., Festin M.R., Deacon J. et al.: "Causes of cervical cancer in the Philippines: a case control study". J. Natl. Cancer Inst., 1998, 90, 43.

[5] Parkin D.M., Pisani P., Ferlay J.: "Estimates of worldwide incidence of 18 major cancers 1985". Int. J. Cancer, 1993, 54, 594.

[6] Pisani P., Parkin D.M., Ferlay J.: "Estimates of worldwide mortality 18 major cancers 1985. Implication and projection of future burden". Int. J. Cancer, 1993, 55, 898.

[7] Herrington C.S.: "Existen los canceres de cervix VPH-negativos? Revalorizaci6n". J. Pathol., 1999, 189, 1.

[8] Dexeus S., Cararach M., Dexeus D.: "The role of colposcopy in modern gynecology". Eur. J. Gynaecol. Oneal., 2002, 23, 269.

[9] Ciotti M., Sesti F., Paba P., Benedetto A., Patrizi L., Criscuolo A et al.: "Human papillomavirus (HPV) testing in the management of women with abnormal pap smears. Experience of a colposcopy referral clinic". Eur. J. Gynaecol. Oneal., 2004, 25, 577.

[10] Rowe L.R., Aldeen W., Bentz J.S.: "Prevalence and typing of HPV by hybrid capture in women with ASCUS, ASC-H and AGC on ThinPrep Pap test". Diagn. Cytopathol., 2004, 30, 426.

[11] Shalay J.C., Dunn T., Byers T., Baron A.E., Douglas J.M. Jr.: "Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears". Obstet. Gynecol., 2000, 96, 410.

[12] Levert M., Clave] C., Graesslin 0., Masure M., Birembaut P., Quereux C. et al.: "Human papillomavirus typing in routine cervical smears. Result from a series of 3778 patients". Gynecol. Obstet. Fertil., 2000, 28, 722.

[13] Wieland U., Pfister H.: "Papillomaviruses in human pathology: Epidemiology, pathogenesis and oncogenic role". In: Gross, Barrosso (eds.), "Human Papilloma Virus Infection. A Clinical Atlas". Ullstein Mosby, Berlin/趴esbaden 1997, 1.

[14] Meisels A.,V ilaplana E.: "Virus de! papilloma humano en dos distintas poblaciones". Ginedips, 1999, 4, 144.

[15] Woodman C.B., Collins S., Winter H. et al.: "Natural history of cervical human papillomavirus infection in young women: a Iongitudinal cohort study". The Lancet, 2001, 157, 1831.

[16] Shlay J.C., Dunn T., Byers T., Baron A.E., Douglas J.M. Jr.: "Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears". Obstet. Gynecol., 2000, 96, 410.